MOONLAKE IMMUNO (MLTX)
(Delayed Data from NSDQ)
$52.76 USD
-0.65 (-1.22%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $52.16 -0.60 (-1.14%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, MoonLake Immunotherapeutics has a market cap of $3.42B, which represents its share price of $53.41 multiplied by its outstanding shares number of 64.01M. As a mid-cap company, MLTX's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MLTX 52.76 -0.65(-1.22%)
Will MLTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MLTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLTX
MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout
Wall Street Analysts Think MOONLAKE IMMUNO (MLTX) Could Surge 106.62%: Read This Before Placing a Bet
MLTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLTX
MoonLake Pharmaceuticals (MLTX) Target Price Raised by Goldman Sachs | MLTX Stock News
Beyond the Balance Sheet: What SWOT Reveals About MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics GAAP EPS of -$0.87 misses by $0.16
MoonLake (MLTX) Reports Strong Q2 with Key Program Progress
MoonLake Immunotherapeutics Reports Q2 2025 EPS of -$0. ...